Quantcast

Latest Diabetic retinopathy Stories

2012-06-14 23:01:19

Bernstein Liebhard LLP reports on a new study linking Actos to diabetic macular edema, a serious eye problem. New York, New York (PRWEB) June 14, 2012 Bernstein Liebhard LLP, a New York law firm nationally recognized for its consumer protection and mass tort practices, reports on a June 11, 2012 study that found that diabetes medications such as Actos may cause a serious eye problem called diabetic macular edema.* The study, published in the Archives of Internal Medicine, found that...

2012-06-11 21:53:45

Researchers at Joslin Diabetes Center hope to use experiences of people with long-term type 1 diabetes to benefit others Researchers at Joslin Diabetes Center, supported by JDRF, have completed a study of 158 people who have lived with type 1 diabetes (T1D) for 50 years or more with eye examinations at Joslin over many decades of follow-up, and have concluded that a high proportion of this unique group of patients developed little to no diabetic eye disease over time. The study focuses on...

2012-05-16 22:29:41

ACE2, a molecule that has been shown to prevent damage in the heart, is now proving to be protective of the major organs that are often damaged in diabetic patients. Gavin Oudit, a researcher with the Faculty of Medicine & Dentistry, and his colleagues at the University of Florida, found that lab models that lacked ACE2 had worse cardiovascular complications related to diabetes. "We show that if you take ACE2 away, they [lab models of diabetes] do very poorly," said Oudit. "It...

2012-05-07 11:02:46

Study proposals could reduce screening costs by around 25 percent Research carried out at the Peninsula College of Medicine and Dentistry (PCMD), University of Exeter, has concluded that it would be a safe and cost-effective strategy to screen people with type 2 diabetes who have not yet developed diabetic retinopathy, for the disease once every two years instead of annually. The research is supported by funding from the National Institute for Health Research Peninsula Collaboration for...

2012-05-07 09:16:34

Nutriceutical offers hope to those facing blindness There may be new found hope for patients whose vision is threatened when medicine injected directly into the eyes fails to cause abnormal blood vessels to recede. While injectable drugs called angiogenesis (an-gee-oh-jen-esis) inhibitors are considered a modern miracle and have become the standard of care for patients with the fast-progressive form of macular degeneration, they are not foolproof. For the first time researchers report that...


Word of the Day
malpais
  • The ragged surface of a lava-flow.
'Malpais' translates from Spanish as 'bad land.'